Literature DB >> 17916799

Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy.

Andrew G Stephen1, Siddhartha A K Datta, Karen M Worthy, Lakshman Bindu, Matthew J Fivash, Kevin B Turner, Daniele Fabris, Alan Rein, Robert J Fisher.   

Abstract

The interaction of the HIV Gag polyprotein with nucleic acid is a critical step in the assembly of viral particles. The Gag polyprotein is composed of the matrix (MA), capsid (CA), and nucleocapsid (NC) domains. The NC domain is required for nucleic acid interactions, and the CA domain is required for Gag-Gag interactions. Previously, we have investigated the binding of the NC protein to d(TG)(n) oligonucleotides using surface plasmon resonance (SPR) spectroscopy. We found a single NC protein is able to bind to more than one immobilized oligonucleotide, provided that the oligonucleotides are close enough together. As NC is believed to be the nucleic acid binding domain of Gag, we might expect Gag to show the same complex behavior. We wished to analyze the stoichiometry of Gag binding to oligonucleotides without this complication due to tertiary complex formation. We have therefore analyzed Gag binding to extremely low oligonucleotide density on SPR chips. Such low densities of oligonucleotides are difficult to accurately quantitate. We have determined by Fourier transform ion cyclotron (FTICR) mass spectrometry that four molecules of NC bind to d(TG)(10) (a 20-base oligonucleotide). We developed a method of calibrating low-density surfaces using NC calibration injections. Knowing the maximal response and the stoichiometry of binding, we can precisely determine the amount of oligonucleotide immobilized at these very-low-density surfaces (<1 Response Unit). Using this approach, we have measured the binding of Gag to d(TG)(10). Gag binds to a 20-mer with a stoichiometry of greater than 4. This suggests that once Gag is bound to the immobilized oligonucleotide, additional Gag molecules can bind to this complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916799      PMCID: PMC2062552     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  14 in total

Review 1.  Electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.

Authors:  C L Hendrickson; M R Emmett
Journal:  Annu Rev Phys Chem       Date:  1999       Impact factor: 12.703

Review 2.  Analysis of noncovalent complexes of DNA and RNA by mass spectrometry.

Authors:  S A Hofstadler; R H Griffey
Journal:  Chem Rev       Date:  2001-02       Impact factor: 60.622

3.  Modulation of HIV-like particle assembly in vitro by inositol phosphates.

Authors:  S Campbell; R J Fisher; E M Towler; S Fox; H J Issaq; T Wolfe; L R Phillips; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 4.  Analysis of nucleic acids by FTICR MS.

Authors:  Steven A Hofstadler; Kristin A Sannes-Lowery; James C Hannis
Journal:  Mass Spectrom Rev       Date:  2005 Mar-Apr       Impact factor: 10.946

5.  Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Authors:  R J Fisher; A Rein; M Fivash; M A Urbaneja; J R Casas-Finet; M Medaglia; L E Henderson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Ordered aggregation of ribonucleic acids by the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  S P Stoylov; C Vuilleumier; E Stoylova; H De Rocquigny; B P Roques; D Gérard; Y Mély
Journal:  Biopolymers       Date:  1997-03       Impact factor: 2.505

Review 7.  Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins.

Authors:  J L Beck; M L Colgrave; S F Ralph; M M Sheil
Journal:  Mass Spectrom Rev       Date:  2001 Mar-Apr       Impact factor: 10.946

8.  Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch.

Authors:  Siddhartha A K Datta; Zhuojun Zhao; Patrick K Clark; Sergey Tarasov; Jerry N Alexandratos; Stephen J Campbell; Mamuka Kvaratskhelia; Jacob Lebowitz; Alan Rein
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

9.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Psi-recognition element.

Authors:  Nathan Hagan; Daniele Fabris
Journal:  Biochemistry       Date:  2003-09-16       Impact factor: 3.162

View more
  4 in total

1.  Virus Matryoshka: A Bacteriophage Particle-Guided Molecular Assembly Approach to a Monodisperse Model of the Immature Human Immunodeficiency Virus.

Authors:  Pooja Saxena; Li He; Andrey Malyutin; Siddhartha A K Datta; Alan Rein; Kevin M Bond; Martin F Jarrold; Alessandro Spilotros; Dmitri Svergun; Trevor Douglas; Bogdan Dragnea
Journal:  Small       Date:  2016-09-16       Impact factor: 13.281

2.  Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications.

Authors:  Tiyun Wu; Siddhartha A K Datta; Mithun Mitra; Robert J Gorelick; Alan Rein; Judith G Levin
Journal:  Virology       Date:  2010-07-23       Impact factor: 3.616

3.  Distinct binding interactions of HIV-1 Gag to Psi and non-Psi RNAs: implications for viral genomic RNA packaging.

Authors:  Joseph A Webb; Christopher P Jones; Leslie J Parent; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  RNA       Date:  2013-06-24       Impact factor: 4.942

4.  Dissecting the oligonucleotide binding properties of a disordered chaperone protein using surface plasmon resonance.

Authors:  Mireille Baltzinger; Kamal Kant Sharma; Yves Mély; Danièle Altschuh
Journal:  Nucleic Acids Res       Date:  2013-09-11       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.